Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 378

1.

The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity.

Tansley SL, Li D, Betteridge ZE, McHugh NJ.

Rheumatology (Oxford). 2020 Feb 6. pii: keaa021. doi: 10.1093/rheumatology/keaa021. [Epub ahead of print]

PMID:
32030410
2.

Genetic analyses of live weight and carcass composition traits in purebred Texel, Suffolk and Charollais lambs.

Fitzmaurice S, Conington J, Fetherstone N, Pabiou T, McDermott K, Wall E, Banos G, McHugh N.

Animal. 2020 Jan 7:1-11. doi: 10.1017/S1751731119002908. [Epub ahead of print]

PMID:
31907100
3.

Autoantibodies in connective tissue disease.

Mulhearn B, Tansley SL, McHugh NJ.

Best Pract Res Clin Rheumatol. 2019 Dec 14:101462. doi: 10.1016/j.berh.2019.101462. [Epub ahead of print] Review.

PMID:
31848055
4.

Exploring the relative value of end of life QALYs: Are the comparators important?

McHugh N, Pinto-Prades JL, Baker R, Mason H, Donaldson C.

Soc Sci Med. 2020 Jan;245:112660. doi: 10.1016/j.socscimed.2019.112660. Epub 2019 Nov 6.

PMID:
31765855
5.

Identification of a novel autoantigen eukaryotic initiation factor 3 associated with polymyositis.

Betteridge Z, Chinoy H, Vencovsky J, Winer J, Putchakayala K, Ho P, Lundberg I, Danko K, Cooper R, McHugh N.

Rheumatology (Oxford). 2019 Sep 17. pii: kez406. doi: 10.1093/rheumatology/kez406. [Epub ahead of print]

PMID:
31728542
6.

Early response to anti-TNF predicts long-term outcomes including sustained remission: an analysis of the BSRBR-RA.

Hamann PDH, Pauling JD, McHugh N, Hyrich K, Shaddick G.

Rheumatology (Oxford). 2019 Nov 12. pii: kez518. doi: 10.1093/rheumatology/kez518. [Epub ahead of print]

PMID:
31714580
7.

The myositis clinical phenotype associated with anti-Zo autoantibodies: a case series of nine UK patients.

Tansley SL, Betteridge Z, Lu H, Davies E, Rothwell S, New PP, Chinoy H, Gordon P, Gunawardena H, Lloyd M, Stratton R, Cooper R, McHugh NJ.

Rheumatology (Oxford). 2019 Oct 26. pii: kez504. doi: 10.1093/rheumatology/kez504. [Epub ahead of print]

PMID:
31665469
8.
9.

Diagnosis and initial management in psoriatic arthritis: a qualitative study with patients.

Dures E, Bowen C, Brooke M, Lord J, Tillett W, McHugh N, Hewlett S.

Rheumatol Adv Pract. 2019 Aug 26;3(2):rkz022. doi: 10.1093/rap/rkz022. eCollection 2019.

10.

Sequence effects in time trade-off valuation of hypothetical health states.

Pinto-Prades JL, McHugh N, Donaldson C, Manoukian S.

Health Econ. 2019 Nov;28(11):1308-1319. doi: 10.1002/hec.3942. Epub 2019 Sep 8.

PMID:
31496009
11.

Long-term effectiveness of tumour necrosis factor-α inhibitor treatment for psoriatic arthritis in the UK: a multicentre retrospective study.

Clunie G, McInnes IB, Barkham N, Marzo-Ortega H, Patel Y, Gough A, Packham J, Kyle S, Kirkham B, Sheeran T, Coope H, Bishop-Bailey A, McHugh N.

Rheumatol Adv Pract. 2018 Oct 17;2(2):rky042. doi: 10.1093/rap/rky042. eCollection 2018.

12.

Exploring the illness representations of people with psoriatic arthritis: a secondary analysis of focus group data.

Erskine G, Dures E, McHugh N, Hewlett S.

Rheumatol Adv Pract. 2018 Aug 8;2(2):rky023. doi: 10.1093/rap/rky023. eCollection 2018.

13.

Evaluation of the Economic Burden of Psoriatic Arthritis and the Relationship Between Functional Status and Healthcare Costs.

McHugh N, Maguire Á, Handel I, Tillett W, Morris J, Hawkins N, Cavill C, Korendowych E, Mughal F.

J Rheumatol. 2019 Aug 15. pii: jrheum.190083. doi: 10.3899/jrheum.190083. [Epub ahead of print]

PMID:
31416922
14.

Comment on: The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis: Reply.

Oldroyd A, Sergeant JC, New RP, McHugh NJ, Betteridge Z, Lamb JA, Ollier WE, Cooper RG, Chinoy H.

Rheumatology (Oxford). 2019 Nov 1;58(11):2073-2074. doi: 10.1093/rheumatology/kez329. No abstract available.

15.

Modifiable risk factors and the development of psoriatic arthritis in people with psoriasis.

Green A, Shaddick G, Charlton R, Snowball J, Nightingale A, Smith C, Tillett W, McHugh N; PROMPT study group.

Br J Dermatol. 2019 Jun 18. doi: 10.1111/bjd.18227. [Epub ahead of print]

PMID:
31209855
16.

Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sjögren's syndrome.

Hackett KL, Davies K, Tarn J, Bragg R, Hargreaves B, Miyamoto S, McMeekin P, Mitchell S, Bowman S, Price EJ, Pease C, Emery P, Andrews J, Lanyon P, Hunter J, Gupta M, Bombardieri M, Sutcliffe N, Pitzalis C, McLaren J, Cooper A, Regan M, Giles I, Isenberg D, Vadivelu S, Coady D, Dasgupta B, McHugh N, Young-Min S, Moots R, Gendi N, Akil M, Griffiths B, Lendrem DW, Ng WF.

RMD Open. 2019 Apr 24;5(1):e000885. doi: 10.1136/rmdopen-2018-000885. eCollection 2019.

17.

Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor-treated rheumatoid arthritis patients.

Hamann PDH, Pauling JD, McHugh N, Shaddick G, Hyrich K; BSRBR-RA Contributors Group .

Rheumatology (Oxford). 2019 Dec 1;58(12):2162-2169. doi: 10.1093/rheumatology/kez188.

18.

Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups.

Rothwell S, Chinoy H, Lamb JA, Miller FW, Rider LG, Wedderburn LR, McHugh NJ, Mammen AL, Betteridge ZE, Tansley SL, Bowes J, Vencovský J, Deakin CT, Dankó K, Vidya L, Selva-O'Callaghan A, Pachman LM, Reed AM, Molberg Ø, Benveniste O, Mathiesen PR, Radstake TRDJ, Doria A, de Bleecker J, Lee AT, Hanna MG, Machado PM, Ollier WE, Gregersen PK, Padyukov L, O'Hanlon TP, Cooper RG, Lundberg IE; Myositis Genetics Consortium (MYOGEN).

Ann Rheum Dis. 2019 Jul;78(7):996-1002. doi: 10.1136/annrheumdis-2019-215046. Epub 2019 May 28.

19.

Comparison of Three Immunoassays for the Detection of Myositis Specific Antibodies.

Mahler M, Betteridge Z, Bentow C, Richards M, Seaman A, Chinoy H, McHugh N.

Front Immunol. 2019 Apr 30;10:848. doi: 10.3389/fimmu.2019.00848. eCollection 2019.

20.
21.

Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients.

Betteridge Z, Tansley S, Shaddick G, Chinoy H, Cooper RG, New RP, Lilleker JB, Vencovsky J, Chazarain L, Danko K, Nagy-Vincze M, Bodoki L, Dastmalchi M, Ekholm L, Lundberg IE, McHugh N; UKMyonet contributors.

J Autoimmun. 2019 Jul;101:48-55. doi: 10.1016/j.jaut.2019.04.001. Epub 2019 Apr 13.

22.

Correction to: Important Treatment Outcomes for Patients with Psoriatic Arthritis: A Multisite Qualitative Study.

Dures E, Hewlett S, Lord J, Bowen C, McHugh N; PROMPT Study Group, Tillett W.

Patient. 2019 Aug;12(4):437. doi: 10.1007/s40271-019-00362-1.

23.

Psoriatic Nail Dystrophy Is Associated with Erosive Disease in the Distal Interphalangeal Joints in Psoriatic Arthritis: A Retrospective Cohort Study.

Antony AS, Allard A, Rambojun A, Lovell CR, Shaddick G, Robinson G, Jadon DR, Holland R, Cavill C, Korendowych E, McHugh NJ, Tillett W.

J Rheumatol. 2019 Sep;46(9):1097-1102. doi: 10.3899/jrheum.180796. Epub 2019 Mar 1.

PMID:
30824637
24.

Patient-reported outcome instruments for assessing Raynaud's phenomenon in systemic sclerosis: A SCTC Vascular Working Group Report.

Pauling JD, Frech TM, Hughes M, Gordon JK, Domsic RT, Anderson ME, Ingegnoli F, McHugh NJ, Johnson SR, Hudson M, Boin F, Ong VH, Matucci-Cerinic M, Altorok N, Scolnik M, Nikpour M, Shah A, Pope JE, Khanna D, Herrick AL.

J Scleroderma Relat Disord. 2018 Oct;3(3):249-252. doi: 10.1177/2397198318774307. Epub 2018 May 24.

25.

Who knows best? A Q methodology study to explore perspectives of professional stakeholders and community participants on health in low-income communities.

McHugh N, Baker R, Biosca O, Ibrahim F, Donaldson C.

BMC Health Serv Res. 2019 Jan 14;19(1):35. doi: 10.1186/s12913-019-3884-9.

26.

Gender stratified adjustment of the DAS28-CRP improves inter-score agreement with the DAS28-ESR in rheumatoid arthritis.

Hamann PDH, Shaddick G, Hyrich K, Green A, McHugh N, Pauling JD; BSRBR-RA Contributors Group.

Rheumatology (Oxford). 2019 May 1;58(5):831-835. doi: 10.1093/rheumatology/key374.

27.

PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials.

Orbai AM, Holland R, Leung YY, Tillett W, Goel N, Christensen R, McHugh N, Gossec L, de Wit M, Højgaard P, Coates LC, Mease PJ, Birt J, Fallon L, FitzGerald O, Ogdie A, Shea B, Strand V, Duffin KC, Tugwell P, Beaton D, Gladman DD.

J Rheumatol. 2019 Aug;46(8):990-995. doi: 10.3899/jrheum.181077. Epub 2018 Dec 15.

PMID:
30554154
28.

The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis.

Oldroyd A, Sergeant JC, New P, McHugh NJ, Betteridge Z, Lamb JA, Ollier WE, Cooper RG, Chinoy H; UKMyoNet.

Rheumatology (Oxford). 2019 Apr 1;58(4):650-655. doi: 10.1093/rheumatology/key357.

29.

The performance of the European League Against Rheumatism/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohort.

Parker MJS, Oldroyd A, Roberts ME, Lilleker JB, Betteridge ZE, McHugh NJ, Herrick AL, Cooper RG, Chinoy H.

Rheumatology (Oxford). 2019 Mar 1;58(3):468-475. doi: 10.1093/rheumatology/key343.

30.

Advancing research paradigms and pathophysiological pathways in psoriatic arthritis and ankylosing spondylitis: Proceedings of the 2017 Platform for the Exchange of Expertise and Research (PEER) meeting.

Abraham S, Barton A, Eder L, Lim A, McGonagle D, McHugh N, Pennington S, Sengupta R, Siebert S, Bowness P, Schafer PH, Cullen E, FitzGerald O.

Semin Arthritis Rheum. 2019 Jun;48(6):1005-1013. doi: 10.1016/j.semarthrit.2018.10.008. Epub 2018 Oct 15. No abstract available.

31.

Histological heterogeneity in a large clinical cohort of juvenile idiopathic inflammatory myopathy: analysis by myositis autoantibody and pathological features.

Yasin SA, Schutz PW, Deakin CT, Sag E, Varsani H, Simou S, Marshall LR, Tansley SL, McHugh NJ, Holton JL, Wedderburn LR, Jacques TS; UK Juvenile Dermatomyositis Research Group (UK and Ireland).

Neuropathol Appl Neurobiol. 2019 Aug;45(5):495-512. doi: 10.1111/nan.12528. Epub 2019 Mar 11.

32.

Trajectory of radiographic change over a decade: the effect of transition from conventional synthetic disease-modifying antirheumatic drugs to anti-tumour necrosis factor in patients with psoriatic arthritis.

Allard A, Antony A, Shaddick G, Jadon DR, Cavill C, Robinson G, Korendowych E, McHugh N, Tillett W.

Rheumatology (Oxford). 2019 Feb 1;58(2):269-273. doi: 10.1093/rheumatology/key297.

PMID:
30247726
33.

Risk of type 2 diabetes and cardiovascular disease in an incident cohort of people with psoriatic arthritis: a population-based cohort study.

Charlton R, Green A, Shaddick G, Snowball J, Nightingale A, Tillett W, Smith C, McHugh N; PROMPT study group.

Rheumatology (Oxford). 2019 Jan 1;58(1):144-148. doi: 10.1093/rheumatology/key286.

PMID:
30202906
34.

Mean difference in live-weight per incremental difference in body condition score estimated in multiple sheep breeds and crossbreds.

McHugh N, McGovern F, Creighton P, Pabiou T, McDermott K, Wall E, Berry DP.

Animal. 2019 Mar;13(3):549-553. doi: 10.1017/S1751731118002148. Epub 2018 Aug 17.

PMID:
30117413
35.

Investigation of myositis and scleroderma specific autoantibodies in patients with lung cancer.

Betteridge ZE, Priest L, Cooper RG, McHugh NJ, Blackhall F, Lamb JA.

Arthritis Res Ther. 2018 Aug 9;20(1):176. doi: 10.1186/s13075-018-1678-9.

36.
37.

Effect of cow replacement strategy on cow and calf performance in the beef herd.

McCabe S, Prendiville R, Evans R, O'Connell NE, McHugh N.

Animal. 2019 Mar;13(3):631-639. doi: 10.1017/S1751731118001660. Epub 2018 Jul 11.

PMID:
29991373
38.

Expression of myxovirus-resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositis.

Soponkanaporn S, Deakin CT, Schutz PW, Marshall LR, Yasin SA, Johnson CM, Sag E, Tansley SL, McHugh NJ, Wedderburn LR, Jacques TS.

Neuropathol Appl Neurobiol. 2019 Jun;45(4):410-420. doi: 10.1111/nan.12498. Epub 2018 Jun 4.

39.

A novel measure of ewe efficiency for breeding and benchmarking purposes.

McHugh N, Pabiou T, McDermott K, Wall E, Berry DP.

J Anim Sci. 2018 Jun 4;96(6):2051-2059. doi: 10.1093/jas/sky143.

40.

Autoantibodies in myositis.

McHugh NJ, Tansley SL.

Nat Rev Rheumatol. 2018 Apr 20;14(5):290-302. doi: 10.1038/nrrheum.2018.56. Review.

PMID:
29674612
41.

Aneuploidy in dizygotic twin sheep detected using genome-wide single nucleotide polymorphism data from two commonly used commercial vendors.

Berry DP, O'Brien A, O'Donovan J, McHugh N, Wall E, Randles S, McDermott K, O'Connor RE, Patil MA, Ho J, Kennedy A, Byrne N, Purfield DC.

Animal. 2018 Dec;12(12):2462-2469. doi: 10.1017/S1751731118000204. Epub 2018 Mar 15.

PMID:
29540254
42.

Factors associated with profitability in pasture-based systems of milk production.

Hanrahan L, McHugh N, Hennessy T, Moran B, Kearney R, Wallace M, Shalloo L.

J Dairy Sci. 2018 Jun;101(6):5474-5485. doi: 10.3168/jds.2017-13223. Epub 2018 Mar 7.

43.

Multinational Qualitative Research Study Exploring the Patient Experience of Raynaud's Phenomenon in Systemic Sclerosis.

Pauling JD, Domsic RT, Saketkoo LA, Almeida C, Withey J, Jay H, Frech TM, Ingegnoli F, Dures E, Robson J, McHugh NJ, Herrick AL, Matucci-Cerinic M, Khanna D, Hewlett S.

Arthritis Care Res (Hoboken). 2018 Sep;70(9):1373-1384. doi: 10.1002/acr.23475. Epub 2018 Aug 16.

44.

A Multicenter Study of the Validity and Reliability of Responses to Hand Cold Challenge as Measured by Laser Speckle Contrast Imaging and Thermography: Outcome Measures for Systemic Sclerosis-Related Raynaud's Phenomenon.

Wilkinson JD, Leggett SA, Marjanovic EJ, Moore TL, Allen J, Anderson ME, Britton J, Buch MH, Del Galdo F, Denton CP, Dinsdale G, Griffiths B, Hall F, Howell K, MacDonald A, McHugh NJ, Manning JB, Pauling JD, Roberts C, Shipley JA, Herrick AL, Murray AK.

Arthritis Rheumatol. 2018 Jun;70(6):903-911. doi: 10.1002/art.40457. Epub 2018 Apr 23.

45.

Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome Registry.

Dumusc A, Ng WF, James K, Griffiths B, Price E, Pease C, Emery P, Lanyon P, Jones A, Bombardieri M, Sutcliffe N, Pitzalis C, Gupta M, McLaren J, Cooper A, Giles I, Isenberg D, Saravanan V, Coady D, Dasgupta B, McHugh N, Young-Min S, Moots R, Gendi N, Akil M, Barone F, Fisher B, Rauz S, Richards A, Bowman S.

Swiss Med Wkly. 2018 Feb 7;148:w14588. doi: 10.4414/smw.2018.14588. eCollection 2018.

46.

Is "end of life" a special case? Connecting Q with survey methods to measure societal support for views on the value of life-extending treatments.

Mason H, Collins M, McHugh N, Godwin J, Van Exel J, Donaldson C, Baker R.

Health Econ. 2018 May;27(5):819-831. doi: 10.1002/hec.3640. Epub 2018 Jan 19.

47.

Proliferative myositis of the latissimus dorsi presenting in a 20-year-old male athlete.

McHugh N, Tevlin R, Beggan C, Ryan DJ, Larkin J, Moloney F, Bennett MW, Kelly J.

Ir Med J. 2017 Aug 8;110(7):605.

PMID:
29341517
48.

Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study.

Herrick AL, Peytrignet S, Lunt M, Pan X, Hesselstrand R, Mouthon L, Silman AJ, Dinsdale G, Brown E, Czirják L, Distler JHW, Distler O, Fligelstone K, Gregory WJ, Ochiel R, Vonk MC, Ancuţa C, Ong VH, Farge D, Hudson M, Matucci-Cerinic M, Balbir-Gurman A, Midtvedt Ø, Jobanputra P, Jordan AC, Stevens W, Moinzadeh P, Hall FC, Agard C, Anderson ME, Diot E, Madhok R, Akil M, Buch MH, Chung L, Damjanov NS, Gunawardena H, Lanyon P, Ahmad Y, Chakravarty K, Jacobsen S, MacGregor AJ, McHugh N, Müller-Ladner U, Riemekasten G, Becker M, Roddy J, Carreira PE, Fauchais AL, Hachulla E, Hamilton J, İnanç M, McLaren JS, van Laar JM, Pathare S, Proudman SM, Rudin A, Sahhar J, Coppere B, Serratrice C, Sheeran T, Veale DJ, Grange C, Trad GS, Denton CP.

Ann Rheum Dis. 2018 Apr;77(4):563-570. doi: 10.1136/annrheumdis-2017-211912. Epub 2018 Jan 6.

49.

Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis.

Pauling JD, Salazar G, Lu H, Betteridge ZE, Assassi S, Mayes MD, McHugh NJ.

Rheumatology (Oxford). 2018 Apr 1;57(4):712-717. doi: 10.1093/rheumatology/kex458.

PMID:
29294089
50.

Morphoea profunda and its relationship to eosinophilic fasciitis.

Wlodek C, Korendowych E, McHugh N, Lovell CR.

Clin Exp Dermatol. 2018 Apr;43(3):306-310. doi: 10.1111/ced.13353. Epub 2017 Dec 26.

PMID:
29277925

Supplemental Content

Loading ...
Support Center